EGR3 and nasopharyngeal carcinoma: It could promote the cell migration and invasion abilities of NPC in vitro by targeting EGR3. These findings provide new insights into the molecular functions of miR-483-5p, which could be used as a promising prognostic biomarker and a potential therapeutic target for NPC patients.